New cancer pill enters human testing for Tough-to-Treat tumors
Disease control
Recruiting now
This is the first human study of an experimental oral medication called ODM-212 for people with advanced solid tumors that have stopped responding to standard treatments. The trial will test the drug's safety, determine the right dose, and see if it shows any anti-cancer activity…
Phase: PHASE1, PHASE2 • Sponsor: Orion Corporation, Orion Pharma • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC